Notify me when Daniel Asher files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EKSO | Ekso Bionics Holdings, Inc. | Ordinary Shares, nominal value $0.01 per share | 17% | $5,866,980 | +$3,081,510 | 677,723 | +111% | DANIEL ASHER | 22 Jan 2026 |
| SQNS | SEQUANS COMMUNICATIONS | Ordinary Shares, nominal value Euro $0.01 per share | 12% | $186,322,990 | +$184,671,743 | 190,125,500 | +11184% | DANIEL ASHER | 16 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|